Consistently, STAT3 siRNA was also demonstrated to enhance anti-tumor immunity by abrogating MDSCs' suppressive function in head and neck squamous cell carcinoma (HNSCC) in another study [82]. This evidence concerns the gene STAT3 and neoplasm.